Trevi Therapeutics

Technology
Biotechnology

Trevi Therapeutics is a drug development company founded in 2011 focused on developing Nalbuphine ER for the severe chronic itching condition known as pruritus.

Suggest edits

Founded

2011

Raised

$98.1M

Follow us

Contributors

Companies in the same industry

Helius Medical
Transplant
EchoPixel, Inc.
Merck
PeptiMed
Edwards Lifesciences
Robert Gould
ZetrOZ Inc
Edison Pharma
Novan Therapeutics

Alexa global traffic share

Index

By TNW

Trevi Therapeutics

Trevi Therapeutics